Search research articles
Contact Us
Filters
Showing results (1-10 of 139) with videos related to
Page
of 14
Sort By:
Medical Care
|
December 4, 2009
Containing cost despite the cost
Joel F Farley
Journal of Managed Care & Specialty Pharmacy
|
June 25, 2019
Are the Benefits of Value-Based Insurance Design Conclusive?
Joel F Farley
Medical Care
|
March 31, 2010
Medicaid prescription cost containment and schizophrenia: a retrospective examination
Joel F Farley
Journal of Managed Care & Specialty Pharmacy
|
October 29, 2024
Potential benefits of incorporating social determinants of health screening on comprehensive medication management effectiveness
Joel F Farley, Swetha Pradeep
Research in Social & Administrative Pharmacy : RSAP
|
January 29, 2011
Patterns and predictors of antipsychotic medication use among the U.S. population: findings from the Medical Expenditure Panel Survey
Chi-Chuan Wang, Joel F Farley
Journal of Health Care for the Poor and Underserved
|
May 11, 2010
Medicaid prescription drug utilization and expenditures following Part D
Joel F Farley, Stacie B Dusetzina
Expert Opinion on Drug Safety
|
February 8, 2021
Comparing the use of individual and composite terms to evaluate adverse drug event disproportionality: a focus on glucagon-like peptide-1 receptor agonists and diabetic retinopathy
Daniel G Dauner, Joel F Farley
Journal of Diabetes and Its Complications
|
October 7, 2023
Utilization and impact of SLGT2 inhibitors among diabetes patients in a nationally representative survey: Findings from NHANES 2013-2020
Tsung-Hua Shen, Joel F Farley
Psychiatric Services (Washington, D.C.)
|
February 4, 2010
Economic grand rounds: did Medicare Part D improve access to medications?
Marisa Elena Domino, Joel F Farley
Journal of the American Pharmacists Association : Japha
|
February 5, 2019
Do enhanced services pharmacies serve sicker patients?
Benjamin Y Urick, Joel F Farley
Page
of 14
Search research articles
Search
Showing results (1-10 of 139) with videos related to
Sort By:
Page
of 14
Medical Care
|
December 4, 2009
Containing cost despite the cost
Joel F Farley
Journal of Managed Care & Specialty Pharmacy
|
June 25, 2019
Are the Benefits of Value-Based Insurance Design Conclusive?
Joel F Farley
Medical Care
|
March 31, 2010
Medicaid prescription cost containment and schizophrenia: a retrospective examination
Joel F Farley
Journal of Managed Care & Specialty Pharmacy
|
October 29, 2024
Potential benefits of incorporating social determinants of health screening on comprehensive medication management effectiveness
Joel F Farley, Swetha Pradeep
Research in Social & Administrative Pharmacy : RSAP
|
January 29, 2011
Patterns and predictors of antipsychotic medication use among the U.S. population: findings from the Medical Expenditure Panel Survey
Chi-Chuan Wang, Joel F Farley
Journal of Health Care for the Poor and Underserved
|
May 11, 2010
Medicaid prescription drug utilization and expenditures following Part D
Joel F Farley, Stacie B Dusetzina
Expert Opinion on Drug Safety
|
February 8, 2021
Comparing the use of individual and composite terms to evaluate adverse drug event disproportionality: a focus on glucagon-like peptide-1 receptor agonists and diabetic retinopathy
Daniel G Dauner, Joel F Farley
Journal of Diabetes and Its Complications
|
October 7, 2023
Utilization and impact of SLGT2 inhibitors among diabetes patients in a nationally representative survey: Findings from NHANES 2013-2020
Tsung-Hua Shen, Joel F Farley
Psychiatric Services (Washington, D.C.)
|
February 4, 2010
Economic grand rounds: did Medicare Part D improve access to medications?
Marisa Elena Domino, Joel F Farley
Journal of the American Pharmacists Association : Japha
|
February 5, 2019
Do enhanced services pharmacies serve sicker patients?
Benjamin Y Urick, Joel F Farley
Page
of 14